Up next

Autoplay

CAR T-Cell Therapy for Relapsed/Refractory CLL

2 Views • 07/14/23
Share
Embed
administrator
administrator
Subscribers
0

The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay